BrainStorm Cell Therapeutics
BCLI
#10383
Rank
C$9.2 M
Marketcap
C$0.83
Share price
12.96%
Change (1 day)
-67.44%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2025 (TTM): -C$15.27 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$15.91 Million, an increase over its 2023 earnings that were of -C$23.53 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$15.27 Million-3.97%
2024 -C$15.91 Million-32.39%
2023 -C$23.53 Million-29.18%
2022 -C$33.22 Million-0.74%
2021 -C$33.46 Million-23.12%
2020 -C$43.52 Million36.8%
2019 -C$31.82 Million66.71%
2018 -C$19.09 Million181.66%
2017 -C$6.78 Million-0.6%
2016 -C$6.82 Million-41.31%
2015 -C$11.62 Million-8.22%
2014 -C$12.66 Million89.74%
2013 -C$6.67 Million42.27%
2012 -C$4.69 Million-12.45%
2011 -C$5.36 Million63.04%
2010 -C$3.29 Million35.52%
2009 -C$2.43 Million-48.99%
2008 -C$4.75 Million-44.39%
2007 -C$8.55 Million
2005 -C$4.43 Million-91.44%
2004 -C$51.69 Million94007.62%
2003 -C$0.06 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
C$2.60 B-17,654.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
C$13.52 B-91,248.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-C$1.09 Billion 7,189.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-C$1.03 Billion 6,832.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
C$28.26 M-290.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-C$0.35 Billion 2,255.61%๐Ÿ‡บ๐Ÿ‡ธ USA